Frequently Asked Question
Multiple clinical studies and ongoing trials demonstrate that MRI-guided ablation provides excellent visibility, strong procedural safety, and the potential to reduce repeat procedures. By enabling direct lesion assessment and eliminating radiation, iCMR represents a next-generation approach to electrophysiology. Programs such as the VISABL-AFL and VISABL-VT trials continue to expand the evidence base for broader indications.
See the following studies:
- Clinical workflow and applicability of electrophysiological cardiovascular magnetic resonance-guided radiofrequency ablation of isthmus-dependent atrial flutter
- Safety, Efficacy, and 2-Year Outcomes of Cardiovascular Magnetic Resonance-Guided Ablation of Isthmus-Dependent Atrial Flutter
- Magnetic resonance imaging–guided conventional catheter ablation of isthmus-dependent atrial flutter using active catheter imaging
More Frequently Asked Questions
Back to All →
How does Imricor’s MRI-guided cardiac ablation system work, and how is it different from traditional fluoroscopy-guided procedures?
Imricor’s system allows physicians to perform cardiac ablations inside the MRI suite using MR-conditional catheters and recording equipment. Instead of...
What makes the Vision-MR Ablation Catheter 2.0 unique?
The Vision-MR Ablation Catheter 2.0 is the first and only commercially available MR-conditional ablation catheter designed for use during real-time...
Which MRI vendors are compatible with Imricor’s iCMR suite?
Imricor’s technology is designed for compatibility with leading MRI systems including Siemens Healthineers and Philips Healthcare. This ensures hospitals can...